Dignify Therapeutics LLC

Home - Dignify Therapeutics

Research Triangle Park, United States · Founded 2015 · $24.1M raised

Employees
1–10
Founded
2015
Total Funding
$24.1M
Last Round
$500K GrantSep 2024
Rounds
15

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

R&D company with 20 SBIR/STTR awards from Department of Health and Human Services.

Summary

Dignify Therapeutics LLC is a Biotech company based in Research Triangle Park, United States, founded in 2015. It has raised $24.1M in total across 15 rounds, most recently a $500K Grant round in Sep 2024. Investors include National Institutes of Health, Eshelman Ventures LLC and RA Capital Management.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

GrantSBIR Phase I (NIH)Sep 2024
$500K

Sign up to see all 15 events

Funding: Seed through Grant. Amounts, valuations, and investors where available.

Investors

Similar Companies

Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Artificial Intelligence, Biotech
Series DTotal funding$1.1BFeb 2025
Alnylam PharmaceuticalsIPO

Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Cambridge, United States1001–5000Biotech, Genomics
Corporate RoundTotal funding$1.0BApr 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Dignify Therapeutics LLC on Indexed.vc
<a href="https://indexed.vc/companies/dignify-therapeutics-llc"><img src="https://indexed.vc/api/badge/company/dignify-therapeutics-llc" alt="Dignify Therapeutics LLC on Indexed.vc" width="260" height="76" /></a>